Braveheart Bio, Inc. (BRVE)
NASDAQ: BRVE · Real-Time Price · USD
23.60
-0.01 (-0.04%)
Sep 23, 2026, 10:10 AM EDT - Market open
Braveheart Bio Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Buy Maintains $48 | Buy | Maintains | $48 | +103.39% | Sep 9, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $45 | Buy | Reiterates | $45 | +90.68% | Sep 9, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $40 | Buy | Initiates | $40 | +69.49% | Aug 31, 2026 |
| TD Cowen | TD Cowen | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Aug 31, 2026 |
| Jefferies No rating | Jefferies | Buy Initiates $48 | Buy | Initiates | $48 | +103.39% | Aug 31, 2026 |